Clinical efficacy of flecainide acetate in atrial fibrillation.

Machine translation Machine translation
作者
类别 Primary study
期刊Cardiology
Year 1990
有症状的房颤(AF)的77名病人接受口服氟卡尼醋酸(247 + / - 8毫克/天)。在66例患者中,以前由1-9种药物的抗心律失常试验。55例中,AF呈阵发性。22例患者呈持续性。转换和/或无房颤复发的40例(52%),氟卡尼和11(14%),氟卡尼和胺碘酮相结合的。平均氟卡尼血清水平为535 + / - 46毫微克/毫升。年龄,是否有冠状动脉疾病或心电图参数用于预测的临床反应。持续性房颤,氟卡尼疗效降低心律失常的持续时间。有关副作用的导通时间(26%)和充血性心脏衰竭(5%)。
Epistemonikos ID: 5fb00ced5c0ab565ce0334aced1112b996003541
First added on: Oct 09, 2012
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use